Abstract
Tension-type headache is a common primary headache with tremendous socioeconomic impact. Establishment of an accurate diagnosis is important before initiation of any pharmacologic therapy. Simple analgesics and nonsteroidal anti-inflammatory drugs are the mainstays of treatment of episodic tension-type headache. The tricyclic antidepressant amitriptyline is the drug of choice in the preventive treatment of chronic tension-type headache. Progress in basic neuroscience has emphasized the importance of nitric oxide inhibition and N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid receptor antagonism in the treatment of chronic pain. It has been demonstrated that inhibition of nitric oxide is effective in chronic tension-type headache. These interesting data indicate that more specific and effective treatment possibilities will emerge in the future.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381–383.
Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147–1157.
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1–96.
von Graffenried B, Nuesch E: Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol 1980, 10(suppl 2):225S-231S.
Diamond S: Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 1983, 23:206z-210z.
Langemark M, Olesen J: Effervescent ASA versus solid ASA in the treatment of tension headache: a double-blind, placebocontrolled study. Headache 1987, 27:90–95.
Martinez-Martin P, Raffaelli E Jr, Titus F, et al.: Efficacy and safety of metamizol vs acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001, 21:604–610.
Nebe J, Heier M, Diener HC: Low-dose ibuprofen in selfmedication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995, 15:531–535.
Peters BH, Fraim CJ, Masel BE: Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 1983, 74:36–42.
Ryan RE: Motrin: a new agent for the symptomatic treatment of muscle contraction headache. Headache 1977, 16:280–283.
Steiner TJ, Lange R, Voelker M: Aspirin in episodic tensiontype headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003, 23:59–66.
Dahlof CG, Jacobs LD: Ketoprofen, paracetamol, and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996, 16:117–123.
Mehlisch DR, Weaver M, Fladung B: Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 1998, 38:579–589.
Migliardi JR, Armellino JJ, Friedman M, et al.: Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994, 56:576–586.
Packman B, Packman E, Doyle G, et al.: Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000, 40:561–567.
Prior MJ, Cooper KM, May LG, Bowen DL: Efficacy and safety of acetaminophen and naproxen in the treatment of tensiontype headache: a randomized, double-blind, placebocontrolled trial. Cephalalgia 2002, 22:740–748.
Schachtel BP, Thoden WR, Konerman JP, et al.: Headache pain model for assessing and comparing the efficacy of over-thecounter analgesic agents. Clin Pharmacol Ther 1991, 50:322–329.
Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tensiontype headache. J Clin Pharmacol 1996, 36:1120–1125.
Steiner TJ, Lange R: Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998, 18:38–43.
Miller DS, Talbot CA, Simpson W, Korey A: A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache 1987, 27:392–396.
Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tensiontype headache. J Clin Pharmacol 1996, 36:1120–1125.
Bigal ME, Bordini CA, Speciali JG: Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache: a placebo-controlled study. Cephalalgia 2001, 21:90–95.
Schachtel BP, Thoden WR: Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988, 28:471–474.
Diamond S, Balm TK, Freitag FG: Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000, 68:312–319.
Harden RN, Rogers D, Fink K, Gracely RH: Controlled trial of ketorolac in tension-type headache. Neurology 1998, 50:507–509.
Kubitzek F, Ziegler G, Gold MS, et al.: Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003, 7:155–162.
Van GervenJMA, Schoemaker RC, Jacobs LD, et al.: Selfmedication of single headache episode with ketoprofen, ibuprofen, or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996, 475–481.
McNeely W, Goa KL: Diclofenac-potassium in migraine: a review. Drugs 1999, 57:991–1003.
Friedman AP, DiSerio FJ: Symptomatic treatment of chronically recurring tension headache: a placebocontrolled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther 1987, 10:69–81.
Jensen R: Tension-type headache. Curr Treat Options Neurol 2001, 3:169–180.
Mathew NT, Schoenen J: Acute pharmacotherapy of tensiontype headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:661–666. A review of numerous studies on the acute pharmacologic treatment of tension-type headache.
Brennum J, Kjeldsen M, Olesen J: The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 1992, 12:375–379.
Cady RK, Gutterman D, Saiers JA, Beach ME: Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997, 17:588–590.
Brennum J, Brinck T, Schriver L, et al.: Sumatriptan has no clinically relevant effect in the treatment of episodic tensiontype headache. Eur J Neurol 1996, 3:23–28.
Goadsby PJ, Lipton RB, Ferrari MD: Migraine: current understanding and treatment. N Engl J Med 2002, 346:257–270.
Bendtsen L: Central sensitization in tension-type headache: possible pathophysiological mechanisms. Cephalalgia 2000, 20:486–508.
Mathew NT, Bendtsen L: Prophylactic pharmacotherapy of tension-type headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:667–673. A comprehensive and interesting review of the pharmacologic prophylactic therapy of chronic tension-type headache.
Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, 1:1236–1239.
Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 11:110–116.
Gobel H, Hamouz V, Hansen C, et al.: Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity, but does not alter pericranial muscle activity readings. Pain 1994, 59:241–249.
Pfaffenrath V, Diener HC, Isler H, et al.: Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multicentre controlled study. Cephalalgia 1994, 14:149–155.
Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285–290.
Bendtsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000, 20:603–610.
Holroyd KA, O’Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208–2215. A well-conducted 6-month trial of amitriptyline and stress management therapy in chronic tension-type headache.
Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21–29.
Watanabe Y, Saito H, Abe K: Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 1993, 32:479–486.
Eschalier A, Ardid D, Dubray C: Tricyclic and other antidepressants as analgesics. In Novel Aspects of Pain Management Opioids and Beyond. Edited by Sawynok JC, Cowan A. Hoboken, NJ: Wiley; 1997:301–319.
Singh NN, Misra S: Sertraline in chronic tension-type headache. J Assoc Physicians India 2002, 50:873–878.
Manna V, Bolino F, Di Cicco L: Chronic tension-type headache, mood depression, and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994, 34:44–49.
Langemark M, Olesen J: Sulpiride and paroxetine in the treatment of chronic tension-type headache: an explanatory double-blind trial. Headache 1994, 34:20–24.
Fogelholm R, Murros K: Tizanidine in chronic tension-type headache: a placebo-controlled, double-blind, cross-over study. Headache 1992, 32:509–513.
Murros K, Kataja M, Hedman C, et al.: Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000, 40:633–637.
Guyer BM: Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999, 3:427–431.
Smuts J, Baker MK, Smuts HM: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999, 6(suppl 4):S99-S102.
Göbel H, Lindner V, Krack PK, et al.: Treatment of chronic tension-type headache with botulinum toxin [Abstract]. Cephalalgia 1999, 19:455.
Rollnik JD, Tanneberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a doubleblind, placebo-controlled study. Headache 2000, 40:300–305.
Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658–664.
Bombardier C: An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002, 89:3D-9D.
Gajraj NM: Cyclooxygenase-2 inhibitors. Anesth Analg 2003, 96:1720–1738.
Yaksh TL, Dirig DM, Conway CM, et al.: The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001, 21:5847–5853.
Fogelholm R, Murros K: Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985, 25:273–275.
Langemark M, Loldrup D, Bech P, Olesen J: Clomipramine and mianserin in the treatment of chronic tension headache: a double-blind, controlled study. Headache 1990, 30:118–121.
Horst WD, Preskorn SH: Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998, 51:237–254.
Morton WA, Sonne SC, Verga MA: Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother 1995, 29:387–395.
Adelman LC, Adelman JU, Von SeggernR, Mannix LK: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572–580.
Kulaksizoglu IB, Cakir S, Ertas M: Treatment of tension-type headache with mirtazapine [Abstract]. Proceedings of the 12th International Headache Research Seminar. Copenhagen: March 7–9, 2003.
Mitsikostas DD, Gatzonis S, Thomas A, Ilias A: Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997, 96:247–251.
Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000, 60:1029–1052.
Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers: potential in the treatment of epilepsy. CNS Drugs 2001, 15:339–350.
Di Trapani G, Mei D, Marra C, et al.: Gabapentin in the prophylaxis of migraine: a double-blind, randomized, placebo-controlled study. Clin Ther 2000, 151:145–148.
Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001, 41:968–975.
Lenaerts M, Bastings E, Sianard J, Schoenen J: Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996, 96:126–129.
Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765–1769.
Ashina M: Neurobiology of chronic tension-type headache. Cephalalgia, in press. A thorough review on the role of nitric oxide in chronic tension-type headache.
Willis WD: Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 2001, 933:142–156.
Woolf CJ, Thompson SW: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of postinjury pain hypersensitivity states. Pain 1991, 44:293–299.
Gu JG, Albuquerque C, Lee CJ, MacDermott AB: Synaptic strengthening through activation of Ca2+-permeable AMPA receptors. Nature 1996, 381:793–796.
Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002, 25:103–126.
Wu J, Lin Q, McAdoo DJ, Willis WD: Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. Neuroreport 1998, 9:589–592.
Mao J, Price DD, Zhu J, et al.: The inhibition of nitric oxideactivated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997, 72:355–366.
Hao JX, Xu XJ: Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 1996, 66:313–319.
Haley JE, Dickenson AH, Schachter M: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31:251–258.
Ramadan NM, Sang C, Chappell A, et al.: IV LY293558, an AMPA/KA receptor antagonist, is effective in migraine [Abstract]. Cephalalgia 2001, 21:267–268.
Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999, 353:287–289. An important study suggesting that inhibition of nitric oxide synthase may become a novel principle in the treatment of chronic tensiontype headache and other pain conditions.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashina, S., Ashina, M. Current and potential future drug therapies for tension-type headache. Current Science Inc 7, 466–474 (2003). https://doi.org/10.1007/s11916-003-0063-8
Issue Date:
DOI: https://doi.org/10.1007/s11916-003-0063-8